Navigation Links
Gene Variant May Raise Risk of Common Eye Disease
Date:4/12/2010

'Good' cholesterol levels linked to age-related macular degeneration, studies show

MONDAY, April 12 (HealthDay News) -- Two new studies provide more evidence of a genetic link between an eye disease that affects millions of older people and the regulation of so-called "good" cholesterol in the body.

The researchers don't fully understand the connection, nor are they near finding better treatments for the eye disease, known as age-related macular degeneration (AMD). Still, they say the results could lead to future advances.

Scientists had been exploring the cholesterol-eye disease link for some time, noted Anand Swaroop, an investigator with the National Eye Institute and lead author of one of the reports. "But somehow, their studies did not get much attention. Hopefully now the genetic evidence is so strong that people will explore those possibilities in much more detail," Swaroop said.

An estimated 10 million or more people in the United States develop AMD each year, including about 25 percent of people over the age of 65 and 30 percent to 35 percent of those over 75, Swaroop said. The disease affects an area of the retina known as the macula, causing people to lose the ability to see in the central area of their field of vision.

"You cannot see straight," Swaroop explained. In the most severe cases, "you cannot drive, and you cannot do day-to-day things in life."

For some patients, the disease can cause blindness.

The cause appears to be a blend of genes and environment. "Genes alone do not cause the disease, and environment alone cannot cause the disease," Swaroop said.

In the new studies, researchers examined the genetic makeup of hundreds of people with and without age-related macular degeneration. Those with the condition turned out to share a particular variant of a gene known as LIPC, which regulates the metabolism of high-density lipoprotein (HDL) cholesterol in the blood.

But what is the link, exactly? It's not clear if high levels of HDL ("good") cholesterol might somehow boost a person's risk of developing the eye disease. That would create a complication if treatments designed to prevent the eye disease harmed cardiovascular health by lowering levels of "good" cholesterol. The reverse -- a treatment that boosted HDL cholesterol but also raised the risk of the eye disease -- would be a problem, too.

In any case, the researchers believe there isn't a direct cause-and-effect relationship, in which the genes in question cause both high levels of good cholesterol and raise the risk of the eye disease.

It's possible that the eye disease might have something to do with how the body transports nutrients in the blood, said Dr. Johanna Seddon, co-author of the other study and director of Tufts University Medical Center's Ophthalmic Epidemiology and Genetics Service.

Or, she said, a third factor might be involved.

In the big picture, said Swaroop, "we know today a lot more than we knew last month and last year." But that doesn't mean a better treatment -- or a cure -- for the eye disease is around the corner.

The studies are published in the April 12-16 online edition of the Proceedings of the National Academy of Sciences.

More information

For more about age-related macular degeneration, try the National Eye Institute.



SOURCES: Anand Swaroop, Ph.D., investigator and chief, Neurobiology Neurodegeneration & Repair Laboratory, National Eye Institute, Bethesda, Md.; Johanna Seddon, M.D., director, Ophthalmic Epidemiology and Genetics Service, Tufts University School of Medicine, Boston; April 12-16, 2010, Proceedings of the National Academy of Sciences, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Genetic Variants in Depressed People Raise Suicide Risk
2. Newly Identified Gene Variants Linked to Diabetes
3. Five Gene Variants May Be Linked to Lung Disease
4. Gene Variant Seems to Guard Against Asthma, COPD
5. Genetic variant associated with aggressive form of prostate cancer
6. Gene Variant Could Lower Alzheimers Risk
7. First Gene Variants Linked to Stuttering Discovered
8. Gene Variant May Help Some Overcome Adversity
9. Genetic Variant Raises Lung Cancer Risk
10. Genetic variant greatly increases lung cancer risk for light smokers
11. Authentidate Holding Corp. Completes Capital Raise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... CA (PRWEB) , ... May 25, 2016 , ... CloudLIMS, ... Promising Pharma and Life Sciences Tech Solution Providers list of 2016 by CIOReview. , ... Promising Pharma and Life Sciences Tech Solution Providers 2016 has been concluded with. The ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Global Wellness Summit (GWS) ... integrative medical wellness offerings of Europe, a continent that pioneered the medical/wellness concept for ... from numerous pioneers in medical wellness, including Henri Chenot, Founder of the Chenot Group, ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... The University ... Nursing and Health Professions. She will lead a team of more than 100 full-time ... will begin her role as dean in late August. , Baker comes to USF ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... has seen a significant spike in their clients' employee participation for their wellness ... health screening by implementing a high-deductible health plan with outcome-based deductible incentives. As ...
(Date:5/25/2016)... ... ... Stern Environmental Group , of Secaucus, New Jersey, working in conjunction ... Real Time Monitoring (RTM) Device. Stern Environmental Group will sell the first monitoring ... use in dormitories, shelters, and nursing homes for real time bedbug monitoring in May ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... CAMBRIDGE, England , May 25, 2016 /PRNewswire/ ... genomics company employing the precision of circulating tumour ... oncology, today announces the appointment of Professor ... will provide medical leadership across the clinical development ... that Inivata,s products help deliver significant improvements in ...
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und ... Überlegenheit in ‚ausgezeichneter plus guter ... Colons    ,      (Logo: ... gab heute neue positive Daten von der MORA-Studie ...
(Date:5/24/2016)... , May 24, 2016  NxStage Medical, Inc. (Nasdaq: ... focused on advancing renal care, today announced that ... participate in the following schedule of investor conferences. Where ... available at http://ir.nxstage.com/ .   ... Healthcare Conference NY, NY           Friday, June 10, 2016 ...
Breaking Medicine Technology: